ACCUSTEM SCIENCES, INC. (ACUT) Operating income 2021–2025
ACCUSTEM SCIENCES, INC. (ACUT) annual operating income history from SEC filings — each fiscal year as reported.
-$1.8MFY2025 · since FY2021: -$670,614 → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.8M | -16.7% |
| FY2024 | -$1.5M | +26.6% |
| FY2023 | -$2.1M | +45.3% |
| FY2022 | -$3.7M | -458.7% |
| FY2021 | -$670,614 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACUT financial trends
ACUT RevenueACUT Net incomeACUT Net marginACUT Gross profitACUT Gross marginACUT Operating marginACUT Operating cash flowACUT Free cash flowACUT Capital expendituresACUT Return on equityACUT Stock buybacksACUT Dividends paidACUT Total assetsACUT Total liabilitiesACUT Shareholders’ equityACUT overview →